Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 81-90 of 167 (Search time: 0.006 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2013Salvage second hematopoietic cell transplantation in myelomaMichaelis, L.; Saad, A.; Zhong, X.; Le-Rademacher, J.; Freytes, C.; Marks, D.; Lazarus, H.; Bird, J.; Holmberg, L.; Kamble, R.; Kumar, S.; Lill, M.; Meehan, K.; Saber, W.; Schriber, J.; Tay, J.; Vogl, D.; Wirk, B.; Savani, B.; Gale, R.; et al.
2013PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancerDay, F.; Jorissen, R.; Lipton, L.; Mouradov, D.; Sakthianandeswaren, A.; Christie, M.; Li, S.; Tsui, C.; Tie, J.; Desai, J.; Xu, Z.; Molloy, P.; Whitehall, V.; Leggett, B.; Jones, I.; McLaughlin, S.; Ward, R.; Hawkins, N.; Ruszkiewicz, A.; Moore, J.; et al.
2021Transcriptional signature in microglia associated with Aβ plaque phagocytosisGrubman, A.; Choo, X.Y.; Chew, G.; Ouyang, J.F.; Sun, G.; Croft, N.P.; Rossello, F.J.; Simmons, R.; Buckberry, S.; Landin, D.V.; Pflueger, J.; Vandekolk, T.H.; Abay, Z.; Zhou, Y.; Liu, X.; Chen, J.; Larcombe, M.; Haynes, J.M.; McLean, C.; Williams, S.; et al.
2021The impact of COVID-19 critical illness on new disability, functional outcomes and return to work at 6 months: a prospective cohort studyHodgson, C.L.; Higgins, A.M.; Bailey, M.J.; Mather, A.M.; Beach, L.; Bellomo, R.; Bissett, B.; Boden, I.J.; Bradley, S.; Burrell, A.; Cooper, D.J.; Fulcher, B.J.; Haines, K.J.; Hopkins, J.; Jones, A.Y.M.; Lane, S.; Lawrence, D.; van der Lee, L.; Liacos, J.; Linke, N.J.; et al.
2015Crohn's disease management after intestinal resection: a randomised trialDe Cruz, P.; Kamm, M.; Hamilton, A.; Ritchie, K.; Krejany, E.; Gorelik, A.; Liew, D.; Prideaux, L.; Lawrance, I.; Andrews, J.; Bampton, P.; Gibson, P.; Sparrow, M.; Leong, R.; Florin, T.; Gearry, R.; Radford-Smith, G.; Macrae, F.; Debinski, H.; Selby, W.; et al.
2023Study protocol for The GOAL Trial: comprehensive geriatric assessment for frail older people with chronic kidney disease to increase attainment of patient-identified goals—a cluster randomised controlled trialLogan, B.; Viecelli, A.; Johnson, D.; Aquino, E.; Bailey, J.; Comans, T.; Gray, L.; Hawley, C.; Hickey, L.; Janda, M.; Jaure, A.; Jose, M.; Kalaw, E.; Kiriwandeniya, C.; Matsuyama, M.; Mihala, G.; Nguyen, K.; Pascoe, E.; Pole, J.; Polkinghorne, K.; et al.
2013Phase III randomized, placebo-controlled study of cetuximab plus brivanib alaninate versus cetuximab plus placebo in patients with metastatic, chemotherapy-refractory, wild-type K-RAS colorectal carcinoma: The NCIC clinical trials group and AGITG co.Siu, L.; Shapiro, J.; Jonker, D.; Karapetis, C.; Zalcberg, J.; Simes, J.; Couture, F.; Moore, M.; Price, T.; Siddiqui, J.; Nott, L.; Charpentier, D.; Liauw, W.; Sawyer, M.; Jefford, M.; Magoski, N.; Haydon, A.; Walters, I.; Ringash, J.; Tu, D.; et al.
2012Glucokinase links Kruppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver diseaseBechmann, L.; Gastaldelli, A.; Vetter, D.; Patman, G.; Pascoe, L.; Hannivoort, R.; Lee, U.; Fiel, I.; Munoz, U.; Ciociaro, D.; Lee, Y.; Buzzigoli, E.; Miele, L.; Hui, K.; Bugianesi, E.; Burt, A.; Day, C.; Mari, A.; Agius, L.; Walker, M.; et al.
2013Loss-of-function mutations in SIM1 contribute to obesity and Prader-Willi-like featuresBonnefond, A.; Raimondo, A.; Stutzmann, F.; Ghoussaini, M.; Ramachandrappa, S.; Bersten, D.; Durand, E.; Vatin, V.; Balkau, B.; Lantieri, O.; Raverdy, V.; Pattou, F.; Van Hul, W.; Van Gaal, L.; Peet, D.; Weill, J.; Miller, J.; Horber, F.; Goldstone, A.; Driscoll, D.; et al.
2015Endovascular therapy for ischemic stroke with perfusion-imaging selectionCampbell, B.; Mitchell, P.; Kleinig, T.; Dewey, H.; Churilov, L.; Yassi, N.; Yan, B.; Dowling, R.; Parsons, M.; Oxley, T.; Wu, T.; Brooks, M.; Simpson, M.; Miteff, F.; Levi, C.; Krause, M.; Harrington, T.; Faulder, K.; Steinfort, B.; Priglinger, M.; et al.